-
effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - specialty journals (American Journal of
Obstetrics and Gynecology, Clinical Cancer Research, Journal of Bone … Bone density
and structure in healthy postmenopausal women
treated with exemestane for the primary … JOURNALS:
American Journal of Obstetrics & Gynecology
Clinical Cancer Research
Journal of Bone … celecoxib: 124
-placebo: 118
Eligible for MAP-
3, not osteoporotic
and not receiving
drugs for bone … Mean age 61.3
years;
Percent change
from baseline to
2 years in bone
mineral density
at the distal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
October 05, 2010 - J
Bone and Joint Surg 2000; 82-A: 304-314.
7. … J Bone and Joint Surg, 2006; 88-A: 472 – 479.
8. … J Bone
and Joint Surg 1974; 56-A: 14-26.
-
effectivehealthcare.ahrq.gov/products/psoriasis-chronic/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
July 17, 2013 - not
appear to cause adverse events associated with systemic
absorption (e.g., adrenal suppression, bone … fracture among
the elderly, and reduced bone growth and height in
children).” … Text revised to state: “Potential adverse events
resulting from systemic absorption, such as impaired bone … fracture among
the elderly, and reduced bone growth and height in
children).” … revised as follows: “Potential adverse events resulting
from systemic absorption, such as impaired bone
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - “An increased risk of bone fracture is now
added to this list, although the strength of association … all PPIs now have a warning in prescribing
information regarding the risk of osteoporosis-related bone … study
appears to neglect a discussion of long-term proton pump inhibitor
(PPI) use and its effect on bone … Bone
Fractures and Proton Pump Inhibitors a. … May 2010, the FDA issued a
consumer update regarding a possible increased risk of bone
outcomes, we
-
effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
January 01, 2012 - As the cartilage that cushions a joint gradually wears away from use, bones rub against each other, … Mesenchymal stem cell (MSC) therapy for OA consists of adult stem cells derived
from the patient’s own bone … The methods used to prepare MSCs
have not yet been standardized; the cells can be isolated from bone … status of II, III, or IV (n=22) who were treated
with a combination of autologous MSC (concentrated bone … Clinical policy bulletin no. 0411:
bone and tendon graft substitutes and
adjuncts. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
February 01, 2014 - occurrence
of lymphomas and/or other cancers, infections, infusion-
and injection-site reactions, bone … Bone fractures (insufficient
data to estimate incidence)
Moderate The risk of bone fracture did not … Bone fractures (insufficient
data to estimate incidence)
Low The risk of bone fracture did not differ … Vertebral fractures and role
of low bone mineral density in Crohn’s disease. … Longitudinal
assessment of growth, mineral metabolism, and bone mass
in pediatric Crohn’s disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - Efficacy and safety of carbon ion radiotherapy in bone and
soft tissue sarcomas. … Heavy charged particle therapy of bone and soft
tissue sarcoma. … [Proton irradiation of
bone metastases] [Russian]. … Chondroblastoma of the apex portion of petrousal
bone. … Chondrosarcoma of the temporal bone.
-
effectivehealthcare.ahrq.gov/products/psoriasis-chronic/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
January 01, 2024 - Previous pelvis irradiation, radical prostatectomy, pelvic nodal disease by CT, distant metastases by bone … T1 to 2, Gleason = 7, and PSA <= 20 ng/mL) without evidence of disease spread to the lymph nodes or bone … high-risk with pelvic nodal involvement risk <15% by updated Partin Tables and negative pelvic CT and bone
-
effectivehealthcare.ahrq.gov/products/gout/consumer
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine/research-protocol
-
effectivehealthcare.ahrq.gov/health-topics/chronic-myeloid-leukemia
-
effectivehealthcare.ahrq.gov/products/vitamin-d-calcium/research-protocol
-
effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research
-
effectivehealthcare.ahrq.gov/health-topics/gum-disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-4.pdf
July 01, 2019 - J Bone Joint Surg Am 2005;87:1438-45 10.2106/JBJS.D.02422, with permission from Rockwater, Inc. … Bone Joint Surg Am 2005;87:1438-45 10.2106/JBJS.D.02422, with permission from
Rockwater, Inc.
7.
-
effectivehealthcare.ahrq.gov/health-topics/osteogenesis-imperfecta
-
effectivehealthcare.ahrq.gov/health-topics/x-rays